Condition: Hiatal Hernia · Sponsor: Tela Bio Inc
This study will evaluate hiatal hernia recurrence rate and post-operative complications following the use of OviTex Core Resorbable or OviTex 1S Resorbable.
This description comes directly from the study's public registry record.
Melissa LaMantia, MA · 757-761-4922 · mlamantia@telabio.com
Danielle Campbell · 717-676-2589 · dcampbell@telabio.com
Always discuss trial participation with your own doctor first.
| University of South Alabama Health | Mobile, Alabama, United States | Recruiting |
| The University of Texas at Austin - Dell Medical School | Austin, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07070115